GHGang Hu

Gang Hu

*This is an algorithmically generated author record based on publicly available information.

Gang Hu has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Jaakko Tuomilehto

    Department of Public Health, University of Helsinki, Helsinki, Finland

    21 shared publications
  • Pekka Jousilahti

    Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland

    16 shared publications
  • Qing Qiao

    From the Department of Epidemiology and Health Promotion (G.H., C.S., P.J., M.P., Q.Q., J.T.), National Public Health Institute, Helsinki; Department of Public Health (G.H., C.S., P.J., M.P., Q.Q., J.T.), University of Helsinki, Helsinki; Oulu City Hospital and Department of Internal Medicine (R.A.), Oulu University, Oulu; and South Ostrobothnia Central Hospital (J.T.), Seinäjoki, Finland

    7 shared publications
  • J. Tuomilehto

    6 shared publications
  • P. Jousilahti

    6 shared publications
  • Riitta Antikainen

    Oulu City Hospital, Oulu, Finland

    5 shared publications

Latest Publications

  • Open Access

    Joint effects of coffee consumption and serum gamma‐glutamyltransferase on the risk of liver cancer†

    by Gang Hu, Jaakko Tuomilehto, Eero Pukkala, Timo Hakulinen, Riitta Antikainen, Erkki Vartiainen, Pekka Jousilahti

    Only three Japanese prospective studies have suggested an inverse association between coffee drinking and liver cancer risk. No prospective studies on the association between serum gamma‐glutamyltransferase (GGT) and liver cancer risk have been reported. We aimed to determine the single and joint associations of coffee consumption and serum GGT with the risk of primary liver cancer. Study cohorts included 60,323 Finnish participants who were 25‐74 years of age and free of any cancer at baseline. During a median follow‐up period of 19.3 years (interquartile range: 9.3‐29.2 years), 128 participants were diagnosed with an incident liver cancer. The multivariable‐adjusted (age, sex, alcohol consumption, education, smoking, diabetes and chronic liver disease at baseline and during follow‐up, and body mass index) hazards ratios of liver cancer in participants who drank 0‐1, 2‐3, 4‐5, 6‐7, and ≥8 cups of coffee daily were 1.00, 0.66, 0.44, 0.38, and 0.32 (P for trend = 0.003), respectively. Further adjustment for serum GGT in subgroup analysis affected the results only slightly. The multivariable‐adjusted and coffee‐adjusted hazard ratio of liver cancer for the highest versus the lowest quartile of serum GGT was 3.13 (95% confidence interval = 1.22‐8.07). The multivariable‐adjusted inverse association between coffee consumption and liver cancer risk persisted when stratified by baseline factors: age more/less than 50 years, current smoker/never smoked/ever smoked, alcohol drinker/never drinker, obese/nonobese, and the highest/lowest three quartiles of serum GGT. A combination of very low coffee consumption and high level of serum GGT was associated with nearly nine‐fold increased risk. Conclusion: Coffee drinking has an inverse and graded association with the risk of liver cancer. High serum GGT is associated with an increased risk of liver cancer. (HEPATOLOGY 2008.)


  • Total cholesterol and the risk of Parkinson disease

    by G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, J. Tuomilehto

    Objective: To examine the association between serum total cholesterol at baseline and the risk of Parkinson disease (PD). Methods: Study cohorts included 24,773 Finnish men and 26,153 women aged 25 to 74 years without a history of PD and stroke at baseline. Hazard ratios (HRs) of incident PD were estimated for different levels of total cholesterol. Results: During a mean follow-up period of 18.1 years, 321 men and 304 women developed incident PD. After adjustment for confounding factors (age, study years, body mass index, systolic blood pressure, education, leisure-time physical activity, smoking, alcohol consumption, coffee and tea consumption, and history of diabetes), the HRs of PD at different levels of total cholesterol (p for trend = 0.035) in men; 1.00, 1.55, 1.57, and 1.86 (p for trend = 0.113) in women; and 1.00, 1.42, 1.56, and 1.86 (p for trend = 0.002) in men and women combined (adjusted also for sex). In both sexes combined, the increased risk of PD associated with increasing levels of serum total cholesterol was present both in subjects aged 25–44 years and in subjects aged 45–54 years at baseline, and in never smokers and smokers; however, no association was found among subjects aged 55 years or older at baseline. Conclusion: This large prospective study suggests that high total cholesterol at baseline is associated with an increased risk of Parkinson disease. GLOSSARY: AD = Alzheimer disease; BMI = body mass index; HR = hazard ratio; MONICA = Monitoring Trends and Determinants of Cardiovascular Disease; PD = Parkinson disease; WHO = World Health Organization.


  • Open Access

    The Increasing Prevalence of Metabolic Syndrome among Finnish Men and Women over a Decade

    by Gang Hu, Jaana Lindström, Pekka Jousilahti, Markku Peltonen, Lena SjöbErg, Risto Kaaja, Jouko Sundvall, Jaakko Tuomilehto

    Objective: Our objective was to assess a 10-yr change in the prevalence of the metabolic syndrome defined by the National Cholesterol Education Program (NCEP) and the International Diabetes Federation (IDF) among Finnish men and women. Design and Subjects: Two cross-sectional population surveys were performed in Finland in 1992 and 2002. A total of 3495 participants aged 45–64 yr were included in the analysis. Results: In both years the metabolic syndrome was more common among men than women. In men the prevalence of the metabolic syndrome tended to increase slightly between 1992 and 2002, from 48.8–52.6% (P = 0.139) based on the NCEP definition, and from 51.4–55.6% based on the IDF definition (P = 0.102). In women the prevalence of the metabolic syndrome increased significantly from 32.2–39.1% based on the NCEP definition (P = 0.003), and from 38.0–45.3% based on the IDF definition (P = 0.002). In both sexes the prevalence of high blood pressure decreased, but the abnormalities in glucose metabolism increased between 1992 and 2002. The prevalence of central obesity increased in women between 1992 and 2002. Conclusions: In Finland the prevalence of the metabolic syndrome, based both on the NCEP and IDF definitions, is higher in men than women. However, the increase in the prevalence of the metabolic syndrome, from 1992–2002, was significant only among women.


  • Open Access

    Coffee consumption and type 2 diabetes — An extensive review

    by Siamak Bidel, Gang Hu, Jaakko Tuomilehto

    Coffee is a complex mixture of potentially active chemicals. It contains significant amounts of phenolic polymers, chlorogenic acid and also caffeine. Agricultural factors, roasting, blending, and brewing determine coffee’s chemical composition. Recent epidemiological studies suggest that habitual coffee consumption may help to prevent some chronic diseases including type 2 diabetes. Despite reports from the clinical trials of the effect of caffeine on decreasing insulin sensitivity, long-term prospective studies revealed that coffee may improve fasting glucose, glucose tolerance and insulin sensitivity as well. In the most recent publication habitual coffee drinkers have a lower total and cardiovascular mortality rate among diabetic subjects.


  • Open Access

    Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease

    by Gang Hu, Pekka Jousilahti, Jaakko Tuomilehto

    To evaluate the joint associations of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the incidence of coronary heart disease (CHD) and CHD mortality. Study cohorts included 49 775 Finnish subjects aged 25–74 without history of CHD and stroke. The multivariable-adjusted hazard ratios (HRs) of CHD incidence were 1.25, 1.69, 1.25, 1.83, 1.85, 2.39, 2.15, and 3.31 (P-value for trend P-value for trend <0.001), respectively. The impact on CHD mortality associated with the different strata of hypertension and diabetes was almost the same or a little stronger compared with that on the CHD incidence. Hypertension and type 2 diabetes increase the CHD risk independently, and their combination increases the risk dramatically, particularly in women.


  • Occupational, commuting and leisure-time physical activity in relation to coronary heart disease among middle-aged Finnish men and women

    by Gang Hu, Pekka Jousilahti, Katja Borodulin, Noël C. Barengo, Timo A. Lakka, Aulikki Nissinen, Jaakko Tuomilehto


  • Coffee and tea consumption and the risk of Parkinson's disease

    by Gang Hu, Siamak Bidel, Pekka Jousilahti, Riitta Antikainen, Jaakko Tuomilehto

    Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow‐up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate‐adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure‐time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1–4, and ≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate‐adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20–0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD. © 2007 Movement Disorder Society


  • Open Access

    Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women

    by Gang Hu, Pekka Jousilahti, Aulikki Nissinen, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto

    Background: Only 2 prospective studies have previously investigated the association between coffee consumption and incident hypertension, and the findings are equivocal. Objective: The objective was to determine the relation between coffee consumption and the incidence of antihypertensive drug treatment. Design: We prospectively followed 24 710 Finnish subjects aged 25–64 y without a history of antihypertensive drug treatment, coronary heart disease, or stroke at baseline. Daily coffee consumption was assessed by questionnaires. Results: During a mean follow-up period of 13.2 y, 2505 participants started antihypertensive drug treatment. The multivariate-adjusted (age, sex, study year, education, leisure-time physical activity, smoking, body mass index, high total cholesterol, history of diabetes, and alcohol, tea, fruit, vegetable, sausage, and bread consumption) hazard ratios for antihypertensive drug treatment associated with the amount of coffee consumed daily (0–1, 2–3, 4–5, 6–7, or ≥8 cups) were 1.00, 1.29 (95% CI: 1.09, 1.54), 1.26 (95% CI: 1.06, 1.49), 1.24 (95% CI: 1.04, 1.48), and 1.14 (95% CI: 0.94, 1.37) (P for trend = 0.024), respectively. This trend became marginally significant after additional adjustment for baseline systolic blood pressure (P for trend = 0.077). Conclusions: The results indicate that coffee drinking seems to increase the risk of antihypertensive drug treatment, and this risk was higher in subjects with low-to-moderate coffee intakes; however, there was no significantly increased trend in drinkers of ≈1 cup (100 mL)/d or ≥8 cups/d.


  • Open Access

    Body Mass Index, Waist Circumference, and Waist-Hip Ratio on the Risk of Total and Type-Specific Stroke

    by Gang Hu, Jaakko Tuomilehto, Karri Silventoinen, Cinzia Sarti, Satu Männistö, Pekka Jousilahti

    Adiposity is an established risk factor for cardiovascular disease,1,2 but the association between adiposity and cerebrovascular disease is still to some extent unclear. Some prospective studies3-9 have found that a high body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) may increase the risk of total stroke, especially ischemic stroke. However, this association disappeared after adjustment for other risk factors, indicating that the effect of BMI on the risk of stroke is mediated through other factors, especially hypertension.3-5,9 Other studies have found no association10,11 or a low BMI associated with a higher risk of stroke.12 In addition, the association between BMI and hemorrhagic stroke remains unclear. Some studies have shown an increased risk of hemorrhagic stroke among lean persons,5,9,12 but other studies have found a J-shaped association,8 no association,7 or an increased risk with increasing BMI.6